We sought to evaluate the predictive validity of the Waterlow Scale in hospitalized patients.
■ Introduction
A pressure ulcer (PU) is defined as a localized injury to the skin and/or underlying tissue usually over a bony prominence, as a result of pressure or pressure in combination with shear and/or friction. 1 They are increasingly recognized as a significant public health problem resulting in hospitalization, institutionalization, loss of quality of life, and high cost. Few studies regarding the incidence of PU are available in Brazil; reported incidences range from 0.94% to 39.81% in hospitalized patients. 2, 3 These incidence rates are broadly comparable to international rates. [4] [5] [6] [7] Because of their negative consequences, prevention is now considered an essential component of a program to manage PU. Multiple factors are associated with an increased likelihood of pressure ulceration, including comorbid conditions, the patient's nutritional status, mobility, incontinence, and coexisting infection. In addition, iatrogenic factors such as the hospital mattress or support surface, seat cushions, the effects of medications, skin care, and other treatments also influence PU risk. [8] [9] [10] [11] The need to recognize potential risk factors and manipulate modifiable factors has prompted the development of multiple tools for assessing PU risk. They perform 2 basic functions: identify patients at risk of developing PU and guide preventive interventions. 12 According to Schoonhoven and associates, 13 there are more than 40 risk assessment scales for PU, but only 2, the Braden and Waterlow scales, have been adapted and validated for use J WOCN ■ Volume 36/Number 6 Serpa et al 641 in Brazil. Since the Waterlow Scale is less studied in Brazil and has recently been translated and adapted for our language, 14 the aim of the present investigation was to analyze the predictive validity of this scale for the development of PU in hospitalized patients.
■ Methods
The present methodological study was conducted by using data from the database of the study of Serpa and Santos. 15, 16 In the original study, data were collected from all hospitalization units of a medium-size general private hospital in the city of São Paulo. The hospital has 220 beds divided among 13 hospitalization units. Attending mainly surgical patients, the mean time of hospitalization is 7.4 days and the occupation rate is approximately 80%. The institution uses nursing care process and provides protocols for the prevention and treatment of PU. The Braden Scale has been used systematically in the hospital since January 2005.
Data were collected after approval of the research project by the ethics committee of the institution. After invitation to participate in the study, the patient or his legal representative received detailed information about the objective of the study and, after agreeing to participate, signed 2 copies of the free informed consent form, with one copy remaining with the patient and the other with the researchers.
All patients hospitalized from January to July 2006 were evaluated, and those fulfilling the following criteria were included in the sample: age equal to 18 years or older, absence of PU at the first assessment, hospitalization for a minimum period of 24 hours and a maximum period of 48 hours, a total Braden Scale score equal to 18 or less and Waterlow Scale score equal to 16 or more, and consent to participate in the study. According to the criteria of the original study, patients with chronic renal failure, patients on dialysis for more than 1 month, and patients with liver insufficiency accompanied by ascites were excluded. From a total of 187 patients admitted to the hospital, during 6 consecutive months, 98 composed the final sample according to the inclusion and exclusion criteria. Seventyfour patients were discharged before completing 3 consecutive assessments, 9 refused to participate, 2 died before completing data collection, and 4 did not have nutritional assessment (criterion for original study).
Instruments
Three instruments were used for data collection: (1) a clinical data form designed for the study, (2) a Portuguese language version of the Braden Scale adapted and validated for use in Brazilian healthcare facilities, 17 and (3) a Portuguese language version of the Waterlow Scale. 14 The clinical data form was completed during the initial assessment. The Brazilian versions of the Braden and Waterlow instruments were completed during the initial assessment and at 48-hour intervals as long as the patient remained at risk or until any of the following study end-points occurred: (1) development of a PU, (2) discharge or transfer from the intensive care unit, or (3) death. Only data from patients with at least 3 consecutive assessments were included in our analysis. The clinical data form and the Waterlow Scale were completed by one of the research team. However, since the Braden Scale is routinely used in the institution, the Braden Scale scoring was completed by staff nurses in the intensive care units.
In 1985, Waterlow proposed a scale that would serve as a guide for the evaluation of PU risk. 18 Although the Norton Scale was already available for this purpose, Waterlow's objective was to develop a more sensitive tool that would incorporate a larger and more varied set of associated factors. 19 The Waterlow Scale includes the following subscales: weight/height (body mass index), skin type visual risk, sex/age, continence, mobility, appetite, and medications. Other factors are evaluated that are not included in the subscales; they are categorized as special risk factors and include tissue malnutrition, neurological defect, and major surgery/trauma. The instrument also provides, on its reverse side, a list of preventive measures that should be applied according to the score obtained. Individual item scores are added to calculate a risk score. In contrast to the Braden Scale, the higher the score, the greater the risk of the development of PU. The scale score varies from 10 to 34, and the total score is used to classify the patient as at risk for developing PU (10) (11) (12) (13) (14) ; high risk of developing PU (15 to 19); and very high risk of developing PU (Ն20). 8 The Waterlow Scale is currently the most widely used instrument in the United Kingdom.
Data Analysis
The predictive validity of the Waterlow Scale for the development of PU in hospitalized patients was analyzed by using 2 methods: receiver operating characteristic (ROC) curve and likelihood ratio (LR). Box 1 provides a glossary of terms used for data analysis. The ROC curve is a graphic plot comparing true-positive values (sensitivity) on the The LR, also called ratio of probability, is another method used to analyze specificity and sensitivity. In the present study, the LR was used to express the higher (or lower) chance of finding a PU in patients at risk compared to those classified as not being at risk. 20, 21 The LR was then applied to the optimum cutoff score identified in the ROC curve. This is an innovative and powerful analysis for the evaluation of a diagnostic test because it permits a more precise description of its performance than does the simple calculation of sensitivity and specificity. 20, 21 A positive LR (LRϩ) of the Waterlow Scale is the ratio between the proportion of patients who develop PU and who are classified as being at risk and the proportion of patients who do not develop PU and who are classified as being at risk. A negative LR (ϪLR) of the Waterlow Scale is obtained when the result of the test is negative, that is, the proportion of patients who develop PU and who are not classified as being at risk divided by the proportion of patients without PU and who are not classified as being at risk. The LR results are represented by the Fagan nomograms. 20 The MS Excel software, Version 2000, was used for construction of the database; the SPSS for Windows program, Version 13.0, for the statistical analyses and elaboration of the graphs; and the MS Word program, Version 2003, for construction of the tables. P value less than 5% was considered as significant. Descriptive statistics such as age, days of hospitalization, and the Braden Scale score were used to describe demographic and clinical data.
■ Results
The sample comprised 98 patients who were homogeneously distributed according to gender. Their mean age (ϮSD) was 71.1 Ϯ 15.5 years (range 29-96 years). The majority (n ϭ 62 or 63.3%) were older than 71 years. Sixtyseven (68.4%) patients were hospitalized for 6 to 12 days. Analysis of the clinical characteristics identified neurological disorders as the most admitting diagnosis (19.4%), and common comorbid conditions included hypertension in 39.8% of patients and diabetes mellitus in 24.5%.
During their initial assessment, 30.6% of subjects were classified as low risk, 46.9% as moderate risk, and 22.4% as high risk. Seven developed PU, resulting in 7.14% incidence of hospital-acquired PU. PUs were diagnosed after the second day of hospitalization and were classified as stage I (85.7%) and stage II (14.3%).
As shown in Table 1 , cutoff scores 17, 20, and 20 provided the best sensitivity and specificity in the first, second, and third assessment, respectively. The AUC showed good accuracy only for the cutoff score 17 in the first assessment (0.64) (Figure 1 ).
The probability of developing a PU was 14%, 10%, and 9% in the first, second, and third assessment, respectively, when the test results were positive, and was 3% in the 3 assessments when the test results were negative ( Figure 2) . Thus, the cutoff score 17 in the first assessment presented the best predictive performance.
■ Discussion
PUs continue to pose a problem for healthcare facilities, and hospital-acquired PUs are increasingly seen as an avoidable outcome for most patients. Langemo and colleagues 22 argue that PUs afflict and discourage patients, and they increase the risk for secondary infection, impairing recovery and increasing nursing care time and associated costs. Thus, PU prevention is of the utmost importance and benefit not only for patient but also for the health system. [23] [24] [25] [26] [27] [28] Risk assessment scales are important tools because they enable nurses and other healthcare professionals to identify at-risk patients and to implement appropriate preventive measures. 12 Based on a systematic literature review, Bolton 12 identified level 2 evidence that a risk assessment scale should be administered to all patients with one or more risk factors for PU when admitted to a critical care, orthopedic, cardiovascular, medical, or step-down unit; when entering home care; or when admitted to hospice or a long-term care facility. In Brazil, improvement in pressure ulcer care, which we attribute to an increased presence of WOC nurses, has led to the publication of epidemiologic studies and greater knowledge of the incidence and prevalence of PU in Brazilian healthcare facilities. 3, 14, 16, 17 However, a paucity of evidence persists concerning the predictive validity of risk assessment adapted for use in Brazil, and our nurses continue to use international standards for cutoff scores for both the Braden and Waterlow scales.
Bolton 12 noted that cutoff point scores, essential for differentiation of clinically significant risk for PU development, may vary based on setting. Therefore, determining cutoff scores in Brazilian healthcare facilities is needed. The present study is the first to analyze the predictive validity of the Waterlow Scale in Brazilian hospital patients. We found that a cutoff score of 17 during the initial assessment is the most accurate for predicting PU risk in patients admitted to acute care facilities in Brazil. In contrast to our study, Rocha and Barros 14 found that a cutoff score of 15 achieved the best sensitivity (87%) and J WOCN ■ November/December 2009 specificity (76%) in patients treated in a hospital in Brazil. The higher cutoff score we identified based on both ROC curve and LR analysis may be attributable to variability in the acuity and type of patients enrolled in our study. 12 However, it is also important to consider that risk assessment represents more than one isolated intervention. Instead, it is an ongoing assessment that is influenced by multiple modifiable factors and serves as a basis for flexible care planning rather than as a static evaluation of risk based only on constitutional or nonmodifiable factors. 29 Therefore, risk assessment scores must be combined with individualized clinical nursing judgment, 12, 30 which is fundamental for the interpretation of its results and for the implementation of specific prevention and treatment measures.
Other researchers have investigated the predictive validities of the various PU risk assessment instruments. Wardman 31 compared the Waterlow and Norton scales and observed that the Waterlow Scale was more precise in selecting patients at risk for the development of PU. Nevertheless, the author cautioned that this scale contains multiple items and requires more complex assessment than do other instruments such as the Braden Scale. Pang and Wong 32 compared risk assessment scales for the Norton, Braden, and Waterlow scales in 106 patients in a rehabilitation hospital in Hong Kong. The Waterlow Scale achieved a 95% sensitivity, a 44% specificity, and a positive predictive value of 29%. They concluded that the Waterlow and Braden scales are the most sensitive PU risk assessment instruments available. In a retrospective study involving patients with spinal cord injury with PU admitted over a 5-year period, Wellard and Lo 19 found that the Waterlow Scale was more sensitive and presented a higher prognostic power than did the Braden and Norton scales.
In a prospective cohort study in hospitalized patients, Schoonhoven and coinvestigators 33 found that the Waterlow Scale is more sensitive (89.5%) than the Norton Scale (46.2%) or Braden (43.5%) Scale, but less specific than both of these instruments. A higher AUC was also obtained for the Waterlow Scale (0.61) for scores equal to 10 or more, but with higher cutoff scores obtained in the present study, lower specificity rates were also observed, mainly in the second and third assessment.
In contrast to the previous studies, Jalali and Rezaie 34 observed a better performance of the Gosnell Scale when compared to the Braden, Waterlow, and Norton scales in neurological and orthopedic patients. They ranked the Waterlow Scale the second best, based on 63% sensitivity and 82.5% specificity.
Balzer and coworkers 35 analyzed sensitivity and specificity by using different cutoff points for the Norton, Waterlow, and Braden scales, based on PU development and/or use of preventive measures. By using a cutoff score of 17, the authors reported 48% sensitivity and 90% specificity based on the stricter criterion (development of a PU), as compared to a 27% sensitivity and 98% specificity based on the second criterion, development of a PU or use of preventive measures. Although these results are very different from those of the previous studies and also from those obtained for the present study with the same cutoff score, the authors concluded that the Waterlow Scale achieved the highest overall sensitivity of the instruments, but it also had the lowest specificity of any of the scales.
Shukla and associates 28 prospectively evaluated PU risk in 100 patients in a hospital setting. Twenty percent were classified as at risk, 10% were found to be at high risk, and 7% were classified as at very high risk. Four of 7 patients (57.1%) classified as at very high risk developed a PU as compared with 2 of 10 patients (20%) categorized in the high-risk category. Subjects were monitored for a 2-week period, and preventive measures were implemented on all patients classified as high risk or very high risk. No patient who was classified as not at risk on the Waterlow Scale developed a PU.
Two systematic reviews evaluated data from multiple studies comparing predictive validity in the various PU risk assessment tools including the Waterlow Scale. PancorboHidalgo and coworkers 36 identified multiple studies reporting a comparatively high sensitivity and low specificity in the Waterlow Scale, which is consistent with our findings. Bolton 12 confirmed that the Waterlow Scale, as well as the Braden and Norton scales, was found as valid for PU risk prediction in a variety of healthcare settings and in multiple countries, based on robust (level 1) evidence.
The higher cutoff score (17) identified in both analysis through ROC curve and LR might be explained by expected variations according to the type of patients in which these instruments are tested. 12 However, risk assessment represents more than one isolated intervention. It is an educational activity since it concerns the various intrinsic and extrinsic factors that predispose patients to the development of PU, thus serving as a basis for care planning. 29 It should be associated with clinical nursing judgment, 12, 30 which is fundamental for the interpretation of its results and for the implementation of specific prevention and treatment measures.
Limitations and Recommendations
Despite its most important limitation, our modest sample size, the findings of this study contribute to the sparse evidence base for Brazilian patients and to the international literature, especially via its use of the LR as a measurement of predictive validity. Additional research using this statistical technique is indicated.
■ Conclusion
A Portuguese language version of the Waterlow Scale, adapted for use in Brazil, demonstrated reasonable predictive validity. Comparable to previous studies, its sensitivity was especially robust, although this was achieved at the cost of a lower specificity. We found that a cutoff score of 17 should be used to identify clinically relevant risk for pressure ulceration when an initial Waterlow Scale is completed with hospital admission.
